22 research outputs found
Oxidation-Induced Conformational Changes in Calcineurin Determined by Covalent Labeling and Tandem Mass Spectrometry
The Ca<sup>2+</sup>/calmodulin activated
phosphatase, calcineurin,
is inactivated by H<sub>2</sub>O<sub>2</sub> or superoxide-induced
oxidation, both <i>in vivo</i> and <i>in vitro</i>. However, the potential for global and/or local conformation changes
occurring within calcineurin as a function of oxidative modification,
that may play a role in the inactivation process, has not been examined.
Here, the susceptibility of calcineurin methionine residues toward
H<sub>2</sub>O<sub>2</sub>-induced oxidation were determined using
a multienzyme digestion strategy coupled with capillary HPLCāelectrospray
ionization mass spectrometry and tandem mass spectrometry analysis.
Then, regions within the protein complex that underwent significant
conformational perturbation upon oxidative modification were identified
by monitoring changes in the modification rates of accessible lysine
residues between native and oxidized forms of calcineurin, using an
amine-specific covalent labeling reagent, <i>S</i>,<i>S</i>ā²-dimethylthiobutanoylhydroxysuccinimide ester (DMBNHS),
and tandem mass spectrometry. Importantly, methionine residues found
to be highly susceptible toward oxidation, and the lysine residues
exhibiting large increases in accessibility upon oxidation, were all
located in calcineurin functional domains involved in Ca<sup>2+</sup>/CaM binding regulated calcineurin stimulation. These findings therefore
provide initial support for the novel mechanistic hypothesis that
oxidation-induced global and/or local conformational changes within
calcineurin contribute to inactivation via (i) impairing the interaction
between calcineurin A and calcineurin B, (ii) altering the low-affinity
Ca<sup>2+</sup> binding site in calcineurin B, (iii) inhibiting calmodulin
binding to calcineurin A, and/or (iv) by altering the affinity between
the calcineurin A autoinhibitory domain and the catalytic center
Comprehensive Lipidome Profiling of Isogenic Primary and Metastatic Colon Adenocarcinoma Cell Lines
A āshotgunā lipidomics strategy consisting
of sequential
functional group selective chemical modification reactions coupled
with high-resolution/accurate mass spectrometry and ātargetedā
tandem mass spectrometry (MS/MS) analysis has been developed and applied
toward the comprehensive identification, characterization and quantitative
analysis of changes in relative abundances of >600 individual glycerophospholipid,
glycerolipid, sphingolipid and sterol lipids between a primary colorectal
cancer (CRC) cell line, SW480, and its isogenic lymph node metastasized
derivative, SW620. Selective chemical derivatization of glycerophosphoethanolamine
and glycerophosphoserine lipids using a āfixed chargeā
sulfonium ion containing, d<sub>6</sub>-<i>S</i>,<i>S</i>ā²-dimethylthiobutanoylhydroxysuccinimide ester (d<sub>6</sub>-DMBNHS) reagent was used to eliminate the possibility of
isobaric mass overlap of these species with the precursor ions of
all other lipids in the crude extracts, thereby enabling their unambiguous
assignment, while subsequent selective mild acid hydrolysis of plasmenyl
(vinyl-ether) containing lipids using formic acid enabled these species
to be readily differentiated from isobaric mass plasmanyl (alkyl-ether)
containing lipids. Using this approach, statistically significant
differences in the abundances of numerous lipid species previously
identified as being associated with cancer progression or that play
known roles as mediators in a range of physiological and pathological
processes were observed between the SW480 and SW620 cells. Most notably,
these included increased plasmanylcholine and triglyceride lipid levels,
decreased plasmenylethanolamine lipids, decreased C-16 containing
sphingomyelin and ceramide lipid levels, and a dramatic increase in
the abundances of total cholesterol ester and triglyceride lipids
in the SW620 cells compared to those in the SW480 cells
Comprehensive Lipidome Profiling of Isogenic Primary and Metastatic Colon Adenocarcinoma Cell Lines
A āshotgunā lipidomics strategy consisting
of sequential
functional group selective chemical modification reactions coupled
with high-resolution/accurate mass spectrometry and ātargetedā
tandem mass spectrometry (MS/MS) analysis has been developed and applied
toward the comprehensive identification, characterization and quantitative
analysis of changes in relative abundances of >600 individual glycerophospholipid,
glycerolipid, sphingolipid and sterol lipids between a primary colorectal
cancer (CRC) cell line, SW480, and its isogenic lymph node metastasized
derivative, SW620. Selective chemical derivatization of glycerophosphoethanolamine
and glycerophosphoserine lipids using a āfixed chargeā
sulfonium ion containing, d<sub>6</sub>-<i>S</i>,<i>S</i>ā²-dimethylthiobutanoylhydroxysuccinimide ester (d<sub>6</sub>-DMBNHS) reagent was used to eliminate the possibility of
isobaric mass overlap of these species with the precursor ions of
all other lipids in the crude extracts, thereby enabling their unambiguous
assignment, while subsequent selective mild acid hydrolysis of plasmenyl
(vinyl-ether) containing lipids using formic acid enabled these species
to be readily differentiated from isobaric mass plasmanyl (alkyl-ether)
containing lipids. Using this approach, statistically significant
differences in the abundances of numerous lipid species previously
identified as being associated with cancer progression or that play
known roles as mediators in a range of physiological and pathological
processes were observed between the SW480 and SW620 cells. Most notably,
these included increased plasmanylcholine and triglyceride lipid levels,
decreased plasmenylethanolamine lipids, decreased C-16 containing
sphingomyelin and ceramide lipid levels, and a dramatic increase in
the abundances of total cholesterol ester and triglyceride lipids
in the SW620 cells compared to those in the SW480 cells
Synthesis, Structural Characterization, and Gas-Phase Unimolecular Reactivity of Bis(diphenylphosphino)amino Copper Hydride Nanoclusters [Cu<sub>3</sub>(X)(Ī¼<sub>3</sub>āH)((PPh<sub>2</sub>)<sub>2</sub>NH)<sub>3</sub>](BF<sub>4</sub>), Where X = Ī¼<sub>2</sub>āCl and Ī¼<sub>3</sub>āBH<sub>4</sub>
An electrospray ionization
mass spectrometry (ESI-MS) survey of
the types of cationic copper clusters formed from an acetonitrile
solution containing a 1:1:20 mixture of tetrakisĀ(acetonitrile)ĀcopperĀ(I)
tetrafluoroborate [CuĀ(MeCN)<sub>4</sub>(BF<sub>4</sub>)], bisĀ(diphenylphosphino)Āamine
(dppa = (Ph<sub>2</sub>P)<sub>2</sub>NH = L), and NaBH<sub>4</sub> revealed a major peak, which based on both the accurate masses and
isotope distribution was assigned as [Cu<sub>3</sub>(BH<sub>4</sub>)Ā(H)Ā(L)<sub>3</sub>]<sup>+</sup>. This prompted synthetic efforts
resulting in isolation of the dppa ligated trinuclear copper hydride
nanoclusters, [Cu<sub>3</sub>(Ī¼<sub>2</sub>-Cl)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]Ā(BF<sub>4</sub>) and [Cu<sub>3</sub>(Ī¼<sub>3</sub>-BH<sub>4</sub>)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]Ā(BF<sub>4</sub>), which were subsequently structurally characterized using
high resolution ESI-MS, X-ray crystallography, NMR, and IR spectroscopy.
The X-ray structures reveal a common structural feature of the cation,
in which the three copperĀ(I) ions adopt a planar trinuclear Cu<sub>3</sub> geometry coordinated on the bottom face by a Ī¼<sub>3</sub>-hydride and surrounded by three dppa ligands. ESI-MS of [Cu<sub>3</sub>(<i>Ī¼</i><sub>2</sub>-Cl)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]Ā(BF<sub>4</sub>) and [Cu<sub>3</sub>(Ī¼<sub>3</sub>-BH<sub>4</sub>)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]Ā(BF<sub>4</sub>) produces [Cu<sub>3</sub>(Ī¼<sub>2</sub>-Cl)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]<sup>+</sup> and [Cu<sub>3</sub>(Ī¼<sub>3</sub>-BH<sub>4</sub>)Ā(Ī¼<sub>3</sub>-H)Ā(L)<sub>3</sub>]<sup>+</sup>. The unimolecular gas-phase ion chemistry of these cations
was examined under multistage tandem mass spectrometry conditions
using collision-induced dissociation (CID). CID of both cations proceeds
via ligand loss to give [Cu<sub>3</sub>(Ī¼<sub>3</sub>-H)Ā(X)Ā(L)<sub>2</sub>]<sup>+</sup>, which is in competition with BH<sub>3</sub> loss in the case of X = BH<sub>4</sub>. DFT calculations on the
fragmentation of [Cu<sub>3</sub>(Ī¼<sub>3</sub>-BH<sub>4</sub>)Ā(Ī¼<sub>3</sub>-H)Ā(L<sup>Me</sup>)<sub>3</sub>]<sup>+</sup> suggest that BH<sub>3</sub> loss produces the hitherto elusive [Cu<sub>3</sub>(Ī¼<sub>3</sub>-H)Ā(Ī¼<sub>2</sub><i>-</i>H)Ā(L<sup>Me</sup>)<sub>3</sub>]<sup>+</sup>, which undergoes further
fragmentation via H<sub>2</sub> loss. CID of the deuterium labeled
cluster [Cu<sub>3</sub>(Ī¼<sub>3</sub>-D)Ā(Ī¼<sub>3</sub>-BD<sub>4</sub>)Ā(L)<sub>3</sub>]<sup>+</sup> reveals that the competing
losses of ligand and BD<sub>3</sub> yield [Cu<sub>3</sub>(Ī¼<sub>3</sub>-BD<sub>4</sub>)Ā(Ī¼<sub>3</sub>-D)Ā(L)<sub>2</sub>]<sup>+</sup> and [Cu<sub>3</sub>(D)<sub>2</sub>(L)<sub>3</sub>]<sup>+</sup> as primary products, which subsequently fragment via further losses
of BD<sub>3</sub> or a ligand to give [Cu<sub>3</sub>(D)<sub>2</sub>(L)<sub>2</sub>]<sup>+</sup>. The coordinated hydrides in the latter
ion are activated toward elimination of D<sub>2</sub> to give [Cu<sub>3</sub>(L)<sub>2</sub>]<sup>+</sup>. Loss of HD and 2HD are minor
channels, consistent with higher DFT predicted endothermicities to
form [Cu<sub>3</sub>(D)Ā(L)Ā(L-H)]<sup>+</sup> and [Cu<sub>3</sub>(L-H)<sub>2</sub>]<sup>+</sup>
Altered Lipid Metabolism in Residual White Adipose Tissues of Bscl2 Deficient Mice
<div><p>Mutations in BSCL2 underlie human congenital generalized lipodystrophy type 2 disease. We previously reported that <i>Bscl2</i><b><sup>ā/ā</sup></b> mice develop lipodystrophy of white adipose tissue (WAT) due to unbridled lipolysis. The residual epididymal WAT (EWAT) displays a browning phenotype with much smaller lipid droplets (LD) and higher expression of brown adipose tissue marker proteins. Here we used targeted lipidomics and gene expression profiling to analyze lipid profiles as well as genes involved in lipid metabolism in WAT of wild-type and <i>Bscl2<sup>ā/ā</sup></i> mice. Analysis of total saponified fatty acids revealed that the residual EWAT of <i>Bscl2<sup>ā/ā</sup></i> mice contained a much higher proportion of oleic<sub>18:1n9</sub> acid concomitant with a lower proportion of palmitic<sub>16:0</sub> acid, as well as increased n3- polyunsaturated fatty acids (PUFA) remodeling. The acyl chains in major species of triacylglyceride (TG) and diacylglyceride (DG) in the residual EWAT of <i>Bscl2<sup>ā/ā</sup></i> mice were also enriched with dietary fatty acids. These changes could be reflected by upregulation of several fatty acid elongases and desaturases. Meanwhile, <i>Bscl2<sup>ā/ā</sup></i> adipocytes from EWAT had increased gene expression in lipid uptake and TG synthesis but not de novo lipogenesis. Both mitochondria and peroxisomal Ī²-oxidation genes were also markedly increased in <i>Bscl2<sup>ā/ā</sup></i> adipocytes, highlighting that these machineries were accelerated to shunt the lipolysis liberated fatty acids through uncoupling to dissipate energy. The residual subcutaneous white adipose tissue (ScWAT) was not browning but displays similar changes in lipid metabolism. Overall, our data emphasize that, other than being essential for adipocyte differentiation, Bscl2 is also important in fatty acid remodeling and energy homeostasis.</p></div
De novo lipogenesis and metabolic pathways of MUFA and PUFAs.
<p>Fatty acids are synthesized through de novo lipogenesis (DNL) or converted from dietary palmitic<sub>16:0</sub>, oleic<sub>18:1n9</sub>, linoleic<sub>18:2n6</sub> and Ī±-linolenic<sub>18:3n3</sub> acids to long chain unsaturated fatty acids <i>in vivo</i> by a series of elongation by elongases (Elovl) and desaturation (Ī5 desaturase (Ī5D/Fasd1), Ī6 desaturase (Ī6D/Fads2), or Ī9-desaturase (Ī9D/Scd1)). Fatty acids that accumulate in animal and human tissues are in solid boxes. Fatty acids derived from normal rodent chow diet are shaded in gray.</p
The residual <i>Bscl2</i><i><sup>ā</sup></i><sup><i>/</i><i>ā</i></sup> subcutaneous white adipose tissues were not browning but had similar altered lipid metabolism.
<p>qPCR analyses of BAT specific genes Ucp1 and Elovl3, lipolytic product activated transcription factor PparĪ± and its targeted genes Cpt1Ī± and Acox2 (A); and genes involved in elongation, desaturation and TG synthesis (B) in isolated adipocytes from ScWAT of <i>Bscl2<sup>+/+</sup></i> and <i>Bscl2<sup>ā/ā</sup></i> mice. Each sample was pooled from 3-4 6-week-old nonfasting male wild-type and <i>Bscl2</i><sup>ā/ā</sup> mice (<i>n</i> ā=ā 4ā5). *: P<0.05; **: p<0.005. (C) TLC analysis of total lipids extracted from ScWAT of male non-fasting <i>Bscl2<sup>+/+</sup> and Bscl2<sup>ā/ā</sup></i> mice (nā=ā5ā6). Total lipids from equal amounts of tissue for each genotype were loaded.</p
Lipidomic analysis of DGs by shotgun mass spectrometry of EWAT from <i>Bscl2<sup>+/+</sup></i> and <i>Bscl2<sup>ā/ā</sup></i> mice.
<p>DG species were determined using high resolution ESI-MS and confirmed via product ion scan mode CID-MS/MS as described in Methods (nā=ā3 pooled from 6 animals). Data are expressed as % total DG ion abundance in each genotype. Data are presented as means Ā± SD. *: p<0.05; **: p<0.005. Arrows indicate upregulation or downregulation vs. <i>Bscl<sup>+/+</sup></i> EWAT.</p
Altered fatty acid compositions suggest increased rate of fatty acid mobilization in residual <i>Bscl2<sup>ā/ā</sup></i> EWAT.
<p>A) Identification and quantification of changes in total adipose tissue saponified fatty acids by RP-HPLC. B) Ratio of oleic<sub>18:1n9</sub>/palmitic<sub>16:0</sub> acids. C) End product/precursor ratio of DHA<sub>22:6n3</sub>/Ī±-linolenic<sub>18:3n3</sub> acids. D) Unsaturation index based on the number of double bonds per fatty acyl residue. nā=ā3 with each sample pooled from EWAT fat pads from 2 animals. *: p<0.05; **: p<0.005.</p
Lipidomic analysis of TGs by shotgun mass spectrometry of EWAT from <i>Bscl2<sup>+/+</sup></i> and <i>Bscl2<sup>ā/ā</sup></i> mice.
<p>TG species were determined using high resolution ESI-MS and confirmed via product ion scan mode CID-MS/MS and āMS<sup>3</sup> as described in Methods (nā=ā3 pooled from 6 animals). Data are expressed as % total TG ion abundance in each genotype. Only the 46 TG species observed at >0.1% total TG ion abundance in <i>Bscl2<sup>+/+</sup></i> EWAT are listed. Data are presented as means Ā± SD. *: p<0.05; **: p<0.005. Arrows indicate upregulation or downregulation vs. <i>Bscl<sup>+/+</sup></i> EWAT.</p